This is a working overview of chronic hepatitis B, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-12-29 and is reviewed periodically as new material appears.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Lyophilized thymosin alpha-1 is generally stored at or below minus twenty degrees Celsius, protected from moisture and light. Short-term handling at ambient temperature is possible for dry powder, but reconstituted solutions degrade faster and are usually kept at two to eight degrees Celsius with a defined expiry of days rather than weeks. Repeated freeze-thaw cycles should be avoided because they promote aggregation and loss of potency. Exact limits depend on the formulation and should follow the supplier's documentation.
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
According to the Panel of Experts on Yemen established pursuant to Security Council resolution 2140, the Houthis have carried out a wide range of human rights violations, including violations of international humanitarian law and abuse of women and children. Children as young as 13 have been arrested for "indecent acts" for alleged homosexual orientation or "political cases" when their families do not comply with Houthi ideology or regulations. Minors share cells with adult prisoners, and according to unspecified reports that the Panel has deemed "credible", boys held in Al-Shahid Al-Ahmar police station in Sana'a are systematically raped. Aside from the Panel of Experts, London-based Arabic newspaper Asharq Al-Awsat alleges that the Houthis have revived slavery in Yemen.
Canadian Learning Television, a former name of Oprah Winfrey Network Capitol Land Trust, Washington, USA Compagnie Luxembourgeoise de Radiodiffusion, later RTL Group, Luxembourg media company Culture Commission or "CLT Commission" affiliated with UNESCO
=== Pain management === β-Endorphin has been primarily studied for its influence on nociception (i.e., pain perception). β-endorphin modulates pain perception both in the central nervous system and the peripheral nervous system. When pain is perceived, pain receptors (nociceptors) send signals to the dorsal horn of the spinal cord and then up to the hypothalamus through the release of a neuropeptide called substance P. In the peripheral nervous system, this signal causes the recruitment of T-lymphocytes, white blood cells of the immune system, to the area where pain was perceived. T-lymphocytes release β-endorphin in this localized region, allowing it to bind to opioid receptors, causing direct inhibition of substance P. In the central nervous system, β-endorphin binds to opioid receptors in the dorsal root and inhibits the release of substance P in the spinal cord, reducing the number of excitatory pain signals sent to the brain. The hypothalamus responds to the pain signal by releasing β-endorphin through the periaqueductal grey network, which mainly acts to inhibit the release of GABA, a neurotransmitter which prevents the release of dopamine. Thus, the inhibition of GABA release by β-endorphin allows for a greater release of dopamine, in part contributing to the analgesic effect of β-endorphin. The combination of these pathways reduces pain sensation, allowing for the body to stop a pain impulse once it has been sent.
Refrigerators are the most common type of storage in health facilities as they can hold many vaccines in one single unit. This storage will help temperature-sensitive vaccines to withstand their components, and the surrounding area will always remain between +2° and +8 °C. In developed countries, electric refrigerators (compression units) are wildly used as there is an electricity supply for at least 8 hours per day. If the country doesn't have sufficient electricity, the solar energy refrigerator (photovoltaic units) or bottled gas/kerosene (absorption units) is also reliable. It is important to keep the desired temperature in any of the models in any circumstances and should not be changed.
(1.2) Keey et al. (2000) use a different definition of the fibre saturation point (equilibrium moisture content of wood in an environment of 99% relative humidity). Many properties of wood show considerable change as the wood is dried below the fibre saturation point, including:
Sources: en.wikipedia.org
The South African general staff judged correctly that if these narrow entry points were seriously contested they had the potential to bottleneck the FAPLA brigades. They opted to launch a counteroffensive at the Lomba River, which was the last of the three rivers FAPLA had to cross before reaching Mavinga. The success of the South African counteroffensive was ensured by the rapid collapse of FAPLA's 47 Infantry Brigade, which was tasked with establishing a bridgehead on the Lomba's southern bank. In conventional terms, the FAPLA brigades theoretically possessed more than enough strength and firepower to dislodge UNITA and the SADF from the Lomba River. But they were inadequately trained or experienced to counter the South African blocking force, which was composed of units selected for their experience in mobile bush warfare, and were outmanoeuvred in the thick foliage cover. The Lomba's swampy environment also hampered coordinated actions and allowed the SADF to isolate and rout each brigade in piecemeal engagements. Between September and October 1987 FAPLA suffered almost 2,000 casualties during several failed river crossings. With much of its bridging equipment destroyed, FAPLA abandoned the offensive and ordered its remaining brigades back to Cuito Cuanavale. The Soviet military mission had suffered 3 dead and at least 1 seriously wounded. The SADF had suffered 17 dead and 41 wounded, as well as the loss of 5 armoured vehicles.
nuclear envelope A sub-cellular barrier consisting of two concentric lipid bilayer membranes that surrounds the nucleus in eukaryotic cells. The nuclear envelope is sometimes simply called the "nuclear membrane", though the structure is actually composed of two distinct membranes, an inner membrane and an outer membrane.
=== Cosmetics === Blotting papers are also commonly used in cosmetics to absorb excess sebum oil from the face. They are popularly marketed and have been sold by numerous cosmetic brands worldwide. The papers are often dyed, for wider market appeal, and dusted with salicylic acid and minerals to actively prevent the formation of comedones and acne. However, there is a popular debate of whether blotting papers can help reduce acne by absorbing excess oil, or cause it. The quality of the blotting papers and the use of other ingredients such as mineral oils may be a determining factor.
=== Binding === The interactions between the protein and ligand substantially affect the specificity between the two entities. Electrostatic interactions and Hydrophobic interactions are known to be the most influential in regards to where specificity between two molecules is derived from. The strength of these interactions between the protein and ligand often positively correlate with their specificity for one another. The specificity of a binding process is strongly dependent of the flexibility of the binding partners. A rigid protein is very restricted in its binding possibilities. A flexible protein can adapt its conformation to a larger number of ligands and thus is more promiscuous. As the binding process usually leads to a rigidification of both binding partners in the complex, binding of a flexible protein usually comes with an entropic penalty. This is the main reason for the frequently found positive correlation of binding affinity and binding specificity. Antibodies show a strong correlation between rigidity and specificity. This correlation extends far beyond the paratope of the antibodies
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.